Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Gujarat Kidney and Super Speciality Limited (GKSL)
Market Closed
11 Aug, 22:00
MSE
All
(2)
IN
(2)
MSE
Primary
XNSE
₹
133.
60
-0.3
-0.224%
₹
10.34B
Market Cap
-
P/E Ratio
-
Div Yield
1,186
Volume
-
Eps
₹
133.9
Previous Close
Watching
Watch
Add Transaction
Day Range
133.05
134.75
Year Range
98.25
148.45
Want to track
GKSL
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Statistics
Historical Data
Gujarat Kidney and Super Speciality Limited (GKSL) Statistics
Valuation metrics
Market Cap
10.34B
Enterprise value
8.43B
Trailing P/E (ttm)
52.65
Forward P/E
-
PEG ratio
0.34
Price/Sales (ttm)
12.47
Price/Book (mrq)
28.73
Enterprise Value/Revenue
10.17
Enterprise Value/EBITDA
30.31
Overview
Shares outstanding
78.84M
Float
10.46M
Shares short
-
% Held by insiders
0.89%
% Held by institutions
0%
Average volume (10 days)
28.61K
Average volume (90 days)
131.12K
Price summary
52-Week low
98.25
52-Week high
148.45
Beta
-
50-Day moving average
121.7
200-Day moving average
113.54
Financials
Fiscal year
Fiscal year ends
31 Mar 2026
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.19%
Operating margin
0.18%
Operational effectiveness
Return on assets
0.08%
Return on equity
0.12%
Income Statement
Revenue (ttm)
828.86M
Revenue per share (ttm)
13.32
Quarterly revenue growth (yoy)
2.18%
Gross profit (ttm)
601.31M
EBITDA
302.96M
Net income to common (ttm)
154.97M
Diluted EPS (ttm)
2.49
Quarterly earnings growth (yoy)
2.95%
Balance Sheet
Total cash (mrq)
132.82M
Total cash per share (mrq)
2.13
Total debt (mrq)
291.09M
Total Debt/Equity (mrq)
11.43
Current ratio (mrq)
3.76%
Book value per share (mrq)
4.56
Cash Flow
Cash flow statement
-38.62M
Levered free cash flow (LFCF)
-1.55B